Product NDC: | 0091-3715 |
Proprietary Name: | Univasc |
Non Proprietary Name: | moexipril hydrochloride |
Active Ingredient(s): | 15 mg/1 & nbsp; moexipril hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0091-3715 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020312 |
Marketing Category: | NDA |
Start Marketing Date: | 19950715 |
Package NDC: | 0091-3715-09 |
Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0091-3715-09) |
NDC Code | 0091-3715-09 |
Proprietary Name | Univasc |
Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0091-3715-09) |
Product NDC | 0091-3715 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | moexipril hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19950715 |
Marketing Category Name | NDA |
Labeler Name | UCB, Inc. |
Substance Name | MOEXIPRIL HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |